A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

<div>The expressions and clinical value of TBX5-AS1 in LUAD patients. (a) The expression of TBX5-AS1 was decreased in LUAD samples in contrast to nontumor samples. (b) High expression of TBX5-AS1 correlated with poor OS based on the TCGA.</div>

Journal of Immunology Research

fig7

Figure 7

Figure 7: A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma 